CTRI/2021/01/030796
已完成
未知
Evaluation of Cellular Immunity in SARS-CoV-2 recovered subjects as an alternative to IgG testing - NI
Atrimed Biotech LLP0 个研究点目标入组 60 人待定
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- Atrimed Biotech LLP
- 入组人数
- 60
- 状态
- 已完成
- 最后更新
- 3年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\) Both male and female adult populations aged from 18 to 60 years with background comorbidities such as Type II Diabetes mellitus(DM), hypertension(HTN), Bronchial asthma, Ischemic heart disease(IHD), cerebrovascular accidents(CVA), Thyroid disorders will be included in the study.
- •2\) Convalescent, RTPCR negative for SARS\-CoV2 ( 2 weeks), IgG positive for SARS CoV2 , asymptomatic patients as determined by the principal investigator/ physician.
- •3\) SARS CoV2 frontline workers are included as test subjects.
- •4\) Non health care workers are included as control subjects. 5\) Volunteer is willing and able to comply with all the trial requirements. 5\) All volunteers obtained written informed consent form in English as well as native language, Kannada
排除标准
- •1\) Patients with active COVID\-19 infection( PCR positive, IgM positive).
- •2\) Known patients of HIV, Hepatitis\-B/C , H1N1\.
- •3\) Pregnant and lactating women.
- •4\) Patients with known autoimmune diseases on immuno\-suppressants and steroids.
- •5\) Patients who have participated in another clinical trial within the previous 30 days.
- •6\) Patient not willing to give informed consent form
结局指标
主要结局
未指定
相似试验
尚未招募
不适用
EVALUATION OF CELLULAR IMMUNITY IN SARS-CoV-2 RECOVERED AND/OR VACCINATED SUBJECTS TO SARS-CoV-2 B-1.1.529 (OMICRON) VARIANT BY A SIMPLE CELLULAR IMMUNITY TESTCTRI/2022/02/039925Atrimed Pharmaceuticals Pvt Ltd
已完成
不适用
Immune response to COVID-19 vaccination in patients with autoimmune disorders on various types of immunosuppressive treatmentsImmune response to COVID-19 (SARS-CoV-2 infection) vaccination in patients on immunosuppressive therapyInfections and InfestationsISRCTN68832164Charles University199
尚未招募
不适用
Analysis of the SARS-CoV-2 specific immune response in persons with SARS-CoV-2 infection (COVID-19)07.1 COVID-19DRKS00023086niversitätsklinikum Homburg190
已完成
不适用
Study of Immune Response During SARS-CoV-2 Infection - (COVID-19)New Coronavirus Disease (COVID-19), Infection With SARS-CoV-2NCT04355351Centre Hospitalier Universitaire de Nice303
招募中
不适用
Immunological assessment of SARS-CoV-2 in IENIMINI cohort individuals with influenza like symptoms.COVID19infection caused by SARS-CoV-2 virus1000381610047438NL-OMON54879eids Universitair Medisch Centrum560